News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
804,993 Results
Type
Article (73572)
Company Profile (697)
Press Release (730724)
Section
Business (226202)
Career Advice (3704)
Deals (39133)
Drug Delivery (122)
Drug Development (88806)
Employer Resources (194)
FDA (17718)
Job Trends (17038)
News (385535)
Policy (38542)
Tag
Academia (2974)
Alliances (55651)
Alzheimer's disease (1398)
Approvals (17649)
Artificial intelligence (195)
Bankruptcy (393)
Best Places to Work (12598)
Biotechnology (477)
Breast cancer (219)
Cancer (1648)
Cardiovascular disease (141)
Career advice (3150)
Cell therapy (355)
Clinical research (70816)
Collaboration (628)
Compensation (319)
COVID-19 (2824)
C-suite (147)
Data (1514)
Diabetes (211)
Diagnostics (6742)
Earnings (91688)
Employer resources (167)
Events (126438)
Executive appointments (522)
FDA (18537)
Funding (554)
Gene therapy (247)
GLP-1 (747)
Government (5014)
Healthcare (20785)
Infectious disease (2931)
Inflammatory bowel disease (129)
Interviews (722)
IPO (17595)
Job creations (4934)
Job search strategy (2584)
Layoffs (501)
Legal (9837)
Lung cancer (247)
Manufacturing (243)
Medical device (14467)
Medtech (14472)
Mergers & acquisitions (21784)
Metabolic disorders (576)
Neuroscience (1805)
NextGen: Class of 2025 (7625)
Non-profit (5071)
Northern California (1925)
Obesity (328)
Opinion (253)
Patents (144)
People (63106)
Pharmaceutical (142)
Phase I (21867)
Phase II (30895)
Phase III (23301)
Pipeline (639)
Postmarket research (3237)
Preclinical (9596)
Radiopharmaceuticals (261)
Rare diseases (323)
Real estate (7100)
Regulatory (25433)
Research institute (2644)
Resumes & cover letters (579)
Southern California (1675)
Startups (4177)
United States (17922)
Vaccines (686)
Weight loss (254)
Date
Today (187)
Last 7 days (450)
Last 30 days (2102)
Last 365 days (37490)
2025 (1968)
2024 (37940)
2023 (42567)
2022 (53926)
2021 (58722)
2020 (57667)
2019 (51305)
2018 (39085)
2017 (36786)
2016 (37676)
2015 (43661)
2014 (38254)
2013 (34184)
2012 (36131)
2011 (36208)
2010 (35540)
Location
Africa (1180)
Arizona (214)
Asia (48045)
Australia (8248)
California (4505)
Canada (1590)
China (384)
Colorado (206)
Connecticut (229)
Europe (108243)
Florida (626)
Georgia (158)
Illinois (484)
Indiana (264)
Maryland (748)
Massachusetts (3577)
Michigan (205)
Minnesota (344)
New Jersey (1256)
New York (1256)
North Carolina (929)
Northern California (1925)
Ohio (167)
Pennsylvania (1033)
South America (1557)
Southern California (1675)
Texas (663)
Utah (129)
Washington State (467)
804,993 Results for "wuxi pharmatech co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
Merck Snaps Up WuXi Biologics Facility in Ireland for $500M
The acquisition from Wuxi Biologics, the embattled CDMO named in the BIOSECURE Act, marks another expansion of Merck’s manufacturing operations in Ireland.
January 6, 2025
·
1 min read
·
Annalee Armstrong
BIOSECURE Act
WuXi Biologics Faces Uncertain Future in the U.S. After BIOSECURE Blow
WuXi AppTec looks to unload its Philadelphia manufacturing sites and WuXi Biologics slows its rapid expansion in the U.S. as the companies await the Senate’s review of the BIOSECURE Act that threatens to cut them off from U.S. biopharma.
October 8, 2024
·
5 min read
·
Ben Hargreaves
Podcast
BioSpace
at Meeting on the Mesa, WuXi Considers Selling U.S. Facilities, Big Pharma Layoffs, More
Cell and gene therapy investment rebounds; WuXi Biologics and other companies named in BIOSECURE Act mull options; Bayer, J&J and Pfizer’s recent layoffs; updates from the weight loss space.
October 9, 2024
·
1 min read
·
Heather McKenzie
BIOSECURE Act
WuXi Mulls Sale of Some US, European Operations: FT
The
Financial Times
reported Thursday that WuXi AppTec is looking to sell its cell and gene therapy manufacturing unit, with facilities in Philadelphia, while WuXi Biologics wants to offload some of its production sites in Europe.
October 3, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering
December 31, 2024
·
4 min read
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering
December 26, 2024
·
4 min read
Scrutiny of WuXi Raises Potential Opportunities for Indian CDMOs
As congressional pressure increases on WuXi AppTec and other China-based companies over alleged ties to the Chinese government, India’s contract development and manufacturing organization sector could benefit.
July 3, 2024
·
4 min read
·
Tyler Patchen
Policy
Scrutiny of WuXi Raises Potential Opportunities for Indian CDMOs
As congressional pressure increases on WuXi AppTec and other China-based companies over alleged ties to the Chinese government, India’s contract development and manufacturing organization sector could benefit.
June 25, 2024
·
6 min read
·
Tyler Patchen
Press Releases
Meiji Seika Pharma: Announcement of the Establishment of Local Subsidiary “Taiwan Meiji Pharma Co., Ltd.” in Taiwan
December 25, 2024
·
1 min read
Press Releases
WuXi AppTec Joins the Pharmaceutical Supply Chain Initiative (PSCI)
January 13, 2025
·
2 min read
1 of 80,500
Next
